Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Learn why balancing short and long term goals leads to steadier progress and fewer stressful financial decisions.
28,657 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Millions of retirees could see their monthly checks shift as the Social Security Administration recalculates benefits...
Rackspace Technology posts a tighter loss and higher 2026 profit outlook after a solid Q4, even as shares slip follow...
A respected technical analyst outlines a Fibonacci-driven path that could push XRP to $27, igniting debate as regulat...
A new wave of proptech bundling is reshaping mortgage workflows. Real estate tech started with simplification, but to...
Three Ethereum-native builders reveal the first confidential DeFi yield vault, allowing institutions to earn yields w...
Bitcoin rose to a weekly high near $72,000 as geopolitical tensions intensified, drawing attention to potential short...
Retirees with a $500,000 portfolio face a choice between dividend-driven income and the traditional 4% rule. Early da...
A 17-year-old with income approved secured a $250,000 loan using projected future earnings, not current income, drawi...
Bitcoin climbed through the 65,000 level, signaling fresh momentum. Traders weigh whether the rally will last or fade...
The Trade Desk faced a tougher path after missing Q1 revenue and guiding for a weaker Q2, triggering multiple downgra...
The FTC signals a softer regulatory stance under a Trump administration, even as a new study shows a fifth of America...